Search - tctmd.com

Displaying 401 - 420 of 8552

Sort: Relevancy | Date

Presentation NY Valves 2025

Precedural Planning of TAVR for Aortic Regurgitation

Presenter: Curtiss T. Stinis

June 26, 2025

Presentation NY Valves 2025

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Presenter: Suzanne J. Baron

June 26, 2025

Presentation NY Valves 2025

Surgery or TAVR for Severe Aortic Regurgitation?

Presenter: Basel Ramlawi

June 26, 2025

Presentation NY Valves 2025

TAVR Across the Age Spectrum

Presenter: Molly Ann Szerlip

June 26, 2025

Presentation NY Valves 2025

TAVR for Aortic Regurgitation in 2025: An ALIGN-AR and ARTIST Trial Update

Presenter: Duane S. Pinto

June 26, 2025

Presentation NY Valves 2025

AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond

Presenter: Brian R. Lindman

June 26, 2025

Presentation NY Valves 2025

Timing for Intervention in Aortic Regurgitation

Presenter: Renuka Jain

June 26, 2025

Presentation NY Valves 2025

Where is the Evidence that Watchful Waiting should be the Preferred Strategy for Aortic Stenosis?

Presenter: Sreekanth Vemulapalli

June 26, 2025

Presentation NY Valves 2025

Differences in Utilization, Patient Characteristics & Outcomes Between Medicare Advantage vs. Fee-For-Service Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Christina Lalani

June 26, 2025

Presentation NY Valves 2025

Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Presenter: Ogechukwu Samuel Obi

June 26, 2025

Presentation NY Valves 2025

Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Tamari Lomaia

June 26, 2025

Presentation NY Valves 2025

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

Presenter: Jadon Ray Rajagopal

June 26, 2025

Presentation NY Valves 2025

The Ottawa Mobile Screening Program: Concept and First 18 Months Experience of a Community-Based Out-Reach Cardiovascular Prevention Program

Presenter: David Messika-Zeitoun

June 26, 2025

Presentation NY Valves 2025

SAVR With Y-Incision Aortic Annular Enlargement Outperforms TAVR in Hemodynamics in Women With Native Aortic Stenosis

Presenter: Bo Yang

June 26, 2025

Presentation NY Valves 2025

Case History

Presenter: Philippe Genereux

June 26, 2025

Presentation NY Valves 2025

Outcomes of Transcatheter Aortic Valve Replacement in Patients With and Without Rheumatoid Arthritis: A Propensity Score–Matched Analysis

Presenter: Adham Ramadan

June 26, 2025

Presentation NY Valves 2025

Exploring Baseline Cardiovascular Risk Factors, Demographics, and Perioperative Complications Among Females With Turner Syndrome Undergoing Surgical Aortic Valve Replacement in the United States

Presenter: Eva Garg

June 26, 2025

Presentation NY Valves 2025

Sex-Related Differences in the Management and Outcomes of Patients Across the Spectrum of Aortic Stenosis

Presenter: Augustin Coisne

June 26, 2025

Presentation NY Valves 2025

What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?

Presenter: Sreekanth Vemulapalli

June 26, 2025

Presentation NY Valves 2025

Sex Differences in Characteristics and Outcomes After TAVI-in-TAVI: The PANDORA International Registry

Presenter: Antonio Popolo Rubbio

June 26, 2025

Advertisement

Precedural Planning of TAVR for Aortic Regurgitation

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Surgery or TAVR for Severe Aortic Regurgitation?

TAVR Across the Age Spectrum

TAVR for Aortic Regurgitation in 2025: An ALIGN-AR and ARTIST Trial Update

AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond

Timing for Intervention in Aortic Regurgitation

Where is the Evidence that Watchful Waiting should be the Preferred Strategy for Aortic Stenosis?

Differences in Utilization, Patient Characteristics & Outcomes Between Medicare Advantage vs. Fee-For-Service Patients Undergoing Transcatheter Aortic Valve Replacement

Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

The Ottawa Mobile Screening Program: Concept and First 18 Months Experience of a Community-Based Out-Reach Cardiovascular Prevention Program

SAVR With Y-Incision Aortic Annular Enlargement Outperforms TAVR in Hemodynamics in Women With Native Aortic Stenosis

Case History

Outcomes of Transcatheter Aortic Valve Replacement in Patients With and Without Rheumatoid Arthritis: A Propensity Score–Matched Analysis

Exploring Baseline Cardiovascular Risk Factors, Demographics, and Perioperative Complications Among Females With Turner Syndrome Undergoing Surgical Aortic Valve Replacement in the United States

Sex-Related Differences in the Management and Outcomes of Patients Across the Spectrum of Aortic Stenosis

What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?

Sex Differences in Characteristics and Outcomes After TAVI-in-TAVI: The PANDORA International Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content